Global Rx Irritable Bowel Syndrome (IBS) Drugs Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 310863
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Rx Irritable Bowel Syndrome (IBS) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Rx Irritable Bowel Syndrome (IBS) Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Women accounting for % of the Rx Irritable Bowel Syndrome (IBS) Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While IBS-D Drugs segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Rx Irritable Bowel Syndrome (IBS) Drugs include Ironwood Pharmaceuticals, Bausch Health, Takeda, Sebela Pharmaceuticals, and Allergan, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Rx Irritable Bowel Syndrome (IBS) Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

IBS-D Drugs

IBS-C Drugs

Others

Market segment by Application, can be divided into

Women

Men

Market segment by players, this report covers

Ironwood Pharmaceuticals

Bausch Health

Takeda

Sebela Pharmaceuticals

Allergan

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Rx Irritable Bowel Syndrome (IBS) Drugs product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Rx Irritable Bowel Syndrome (IBS) Drugs, with revenue, gross margin and global market share of Rx Irritable Bowel Syndrome (IBS) Drugs from 2019 to 2022.

Chapter 3, the Rx Irritable Bowel Syndrome (IBS) Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Rx Irritable Bowel Syndrome (IBS) Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Rx Irritable Bowel Syndrome (IBS) Drugs research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Rx Irritable Bowel Syndrome (IBS) Drugs

1.2 Classification of Rx Irritable Bowel Syndrome (IBS) Drugs by Type

1.2.1 Overview: Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type in 2021

1.2.3 IBS-D Drugs

1.2.4 IBS-C Drugs

1.2.5 Others

1.3 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market by Application

1.3.1 Overview: Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Women

1.3.3 Men

1.4 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size & Forecast

1.5 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast by Region

1.5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region, (2017-2022)

1.5.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Prospect (2017-2028)

1.5.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Prospect (2017-2028)

1.5.6 South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers

1.6.2 Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints

1.6.3 Rx Irritable Bowel Syndrome (IBS) Drugs Trends Analysis

2 Company Profiles

2.1 Ironwood Pharmaceuticals

2.1.1 Ironwood Pharmaceuticals Details

2.1.2 Ironwood Pharmaceuticals Major Business

2.1.3 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product and Solutions

2.1.4 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Ironwood Pharmaceuticals Recent Developments and Future Plans

2.2 Bausch Health

2.2.1 Bausch Health Details

2.2.2 Bausch Health Major Business

2.2.3 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Product and Solutions

2.2.4 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Bausch Health Recent Developments and Future Plans

2.3 Takeda

2.3.1 Takeda Details

2.3.2 Takeda Major Business

2.3.3 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Product and Solutions

2.3.4 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Takeda Recent Developments and Future Plans

2.4 Sebela Pharmaceuticals

2.4.1 Sebela Pharmaceuticals Details

2.4.2 Sebela Pharmaceuticals Major Business

2.4.3 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product and Solutions

2.4.4 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Sebela Pharmaceuticals Recent Developments and Future Plans

2.5 Allergan

2.5.1 Allergan Details

2.5.2 Allergan Major Business

2.5.3 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Product and Solutions

2.5.4 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Allergan Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Rx Irritable Bowel Syndrome (IBS) Drugs Players Market Share in 2021

3.2.2 Top 10 Rx Irritable Bowel Syndrome (IBS) Drugs Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Rx Irritable Bowel Syndrome (IBS) Drugs Players Head Office, Products and Services Provided

3.4 Rx Irritable Bowel Syndrome (IBS) Drugs Mergers & Acquisitions

3.5 Rx Irritable Bowel Syndrome (IBS) Drugs New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Market Share by Type (2017-2022)

4.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2017-2022)

5.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2017-2028)

6.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2017-2028)

6.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country

6.3.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Country (2017-2028)

6.3.2 United States Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

6.3.3 Canada Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

6.3.4 Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2017-2028)

7.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2017-2028)

7.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country

7.3.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Country (2017-2028)

7.3.2 Germany Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

7.3.3 France Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

7.3.5 Russia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

7.3.6 Italy Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2017-2028)

8.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2017-2028)

8.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region

8.3.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Region (2017-2028)

8.3.2 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

8.3.3 Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

8.3.4 South Korea Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

8.3.5 India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

8.3.7 Australia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2017-2028)

9.2 South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2017-2028)

9.3 South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country

9.3.1 South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Country (2017-2028)

9.3.2 Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

9.3.3 Argentina Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2017-2028)

10.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2017-2028)

10.3 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country

10.3.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Country (2017-2028)

10.3.2 Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

10.3.4 UAE Rx Irritable Bowel Syndrome (IBS) Drugs Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (USD Million) by Region (2017-2022)

Table 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Region (2023-2028)

Table 6. Ironwood Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 7. Ironwood Pharmaceuticals Major Business

Table 8. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product and Solutions

Table 9. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Bausch Health Corporate Information, Head Office, and Major Competitors

Table 11. Bausch Health Major Business

Table 12. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Product and Solutions

Table 13. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Takeda Corporate Information, Head Office, and Major Competitors

Table 15. Takeda Major Business

Table 16. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Product and Solutions

Table 17. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Sebela Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 19. Sebela Pharmaceuticals Major Business

Table 20. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product and Solutions

Table 21. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Allergan Corporate Information, Head Office, and Major Competitors

Table 23. Allergan Major Business

Table 24. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Product and Solutions

Table 25. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 27. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 28. Breakdown of Rx Irritable Bowel Syndrome (IBS) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)

Table 29. Rx Irritable Bowel Syndrome (IBS) Drugs Players Head Office, Products and Services Provided

Table 30. Rx Irritable Bowel Syndrome (IBS) Drugs Mergers & Acquisitions in the Past Five Years

Table 31. Rx Irritable Bowel Syndrome (IBS) Drugs New Entrants and Expansion Plans

Table 32. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (USD Million) by Type (2017-2022)

Table 33. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Share by Type (2017-2022)

Table 34. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Forecast by Type (2023-2028)

Table 35. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2017-2022)

Table 36. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Forecast by Application (2023-2028)

Table 37. North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2017-2022) & (USD Million)

Table 38. North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2023-2028) & (USD Million)

Table 39. North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2017-2022) & (USD Million)

Table 40. North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2023-2028) & (USD Million)

Table 41. North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Country (2017-2022) & (USD Million)

Table 42. North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Country (2023-2028) & (USD Million)

Table 43. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2017-2022) & (USD Million)

Table 44. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2023-2028) & (USD Million)

Table 45. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2017-2022) & (USD Million)

Table 46. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2023-2028) & (USD Million)

Table 47. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Country (2017-2022) & (USD Million)

Table 48. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Country (2023-2028) & (USD Million)

Table 49. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2017-2022) & (USD Million)

Table 50. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2023-2028) & (USD Million)

Table 51. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2017-2022) & (USD Million)

Table 52. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2023-2028) & (USD Million)

Table 53. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Region (2017-2022) & (USD Million)

Table 54. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Region (2023-2028) & (USD Million)

Table 55. South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2017-2022) & (USD Million)

Table 56. South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2023-2028) & (USD Million)

Table 57. South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2017-2022) & (USD Million)

Table 58. South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2023-2028) & (USD Million)

Table 59. South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Country (2017-2022) & (USD Million)

Table 60. South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Country (2023-2028) & (USD Million)

Table 61. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2017-2022) & (USD Million)

Table 62. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Type (2023-2028) & (USD Million)

Table 63. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2017-2022) & (USD Million)

Table 64. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Application (2023-2028) & (USD Million)

Table 65. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Country (2017-2022) & (USD Million)

Table 66. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Rx Irritable Bowel Syndrome (IBS) Drugs Picture

Figure 2. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type in 2021

Figure 3. IBS-D Drugs

Figure 4. IBS-C Drugs

Figure 5. Others

Figure 6. Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application in 2021

Figure 7. Women Picture

Figure 8. Men Picture

Figure 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Region (2017-2028)

Figure 12. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Region in 2021

Figure 13. North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers

Figure 19. Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints

Figure 20. Rx Irritable Bowel Syndrome (IBS) Drugs Market Trends

Figure 21. Ironwood Pharmaceuticals Recent Developments and Future Plans

Figure 22. Bausch Health Recent Developments and Future Plans

Figure 23. Takeda Recent Developments and Future Plans

Figure 24. Sebela Pharmaceuticals Recent Developments and Future Plans

Figure 25. Allergan Recent Developments and Future Plans

Figure 26. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Share by Players in 2021

Figure 27. Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 28. Global Top 3 Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share in 2021

Figure 29. Global Top 10 Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share in 2021

Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 31. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Share by Type in 2021

Figure 32. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share Forecast by Type (2023-2028)

Figure 33. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Share by Application in 2021

Figure 34. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share Forecast by Application (2023-2028)

Figure 35. North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Type (2017-2028)

Figure 36. North America Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Application (2017-2028)

Figure 37. North America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Country (2017-2028)

Figure 38. United States Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 39. Canada Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 40. Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 41. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Type (2017-2028)

Figure 42. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Application (2017-2028)

Figure 43. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Country (2017-2028)

Figure 44. Germany Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. France Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. United Kingdom Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Russia Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Italy Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Type (2017-2028)

Figure 50. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Application (2017-2028)

Figure 51. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Region (2017-2028)

Figure 52. China Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. South Korea Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. India Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Australia Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Type (2017-2028)

Figure 59. South America Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Application (2017-2028)

Figure 60. South America Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Country (2017-2028)

Figure 61. Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Argentina Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Type (2017-2028)

Figure 64. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Sales Market Share by Application (2017-2028)

Figure 65. Middle East and Africa Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Country (2017-2028)

Figure 66. Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Saudi Arabia Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. UAE Rx Irritable Bowel Syndrome (IBS) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Methodology

Figure 70. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz